Ignite Creation Date:
2024-05-05 @ 11:43 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00114023
Status:
COMPLETED
Last Update Posted:
2007-02-19
First Post:
2005-06-13
Brief Title:
1-Year Follow up to the 1473-IMIQ Study
Sponsor:
Organization:
Graceway Pharmaceuticals LLC
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
84
Enrollment Type:
None
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
| Name |
|---|
| Defined Population |
Time Perspective List:
Clinical Trial Statuses
| Name |
|---|
| 624 |
Who Masked List: